search

Active clinical trials for "COVID-19"

Results 5521-5530 of 7207

Evaluation of the Relationship of Vitamin D and Vitamin D Binding Protein With Disease Severity...

SARS CoV-2 Infection

There were many studies in the literature discussing the effects of vitamin D deficiency and the role of vitamin D supplementation in SARS-CoV-2 patients. Combined with the possible impact of vitamin D on the pathogenesis of SARS-CoV-2 infection, it is concluded that VDBP-regulated bioavailable and free vitamin D concentrations modulate the human immune system response to viral infections. Because of the gap in the literature, it was emphasized that studies should focus on vitamin D binding protein (VDBP) and gene polymorphism. In this study, it was aimed to investigate the relationship between SARS-CoV-2 infection severity and free and bioavailable vitamin D levels.

Completed5 enrollment criteria

A Retrospective Cohort Study of Differential Attainment, COVID-19 and Chaos

SurgeryCOVID-19

A retrospective cohort study of Differential Attainment, COVID and Chaos: taking the difference out of a terrible trinity

Completed2 enrollment criteria

Calcifediol in the Treatment of COVID 19

COVID-19

Patients hospitalized with COVID-19 treated with calcifediol during the first outbreaks of the pandemic (until the first vaccinations) are compared with the aim of determining the therapeutic, clinical, functional, and biochemical variables that modify the response (admission to ICU or death) to calcifediol during hospitalization for COVID 19

Completed5 enrollment criteria

Stellate Ganglion Block to Treat Long COVID 19 Case Series

Long COVIDLong Covid1913 more

An assessment of the effectiveness of Stellate Ganglion Block in alleviating symptoms of Long COVID-19.

Completed3 enrollment criteria

Correlation Between PaCO2 and Respiratory Effort in Patients With COVID-19 With Extracorporeal Membrane...

COVID-19 Acute Respiratory Distress SyndromeExtracorporeal Membrane Oxygenation Complication1 more

Excessive respiratory effort may cause self-inflicted lung injury (SILI) and inspiratory muscle injuries , stimulate desynchronization between the patient and ventilator , and worsen the perfusion of extrapulmonary organs . Appropriate respiratory drive and effort should be maintained during the treatment of patients with respiratory failure . In contrast, respiratory drive and effort are commonly increased in patients with COVID-19 pneumonia , and this phenomenon may persist in critically ill patients with COVID-19, even after receiving venovenous ECMO (vv-ECMO) support, owing to low pulmonary compliance and a high systemic inflammatory state . To reduce respiratory effort and drive, ICU physicians often administer high doses of sedative drugs, analgesics, and muscle relaxants. The prolonged use of high doses of these drugs can cause loss of the spontaneous cough reflex, which in turn impairs sputum drainage and eventually worsens pulmonary consolidation and lung infections. As the partial pressure of carbon dioxide in arterial blood (PaCO2) could affect the respiratory drive from the respiratory center (1), it has been shown that altering different levels of extracorporeal carbon dioxide removal in patients undergoing ECMO recovering from acute respiratory distress syndrome (ARDS) could alter respiratory drive. We hope to find a more appropriate target for maintaining PaCO2 to control respiratory effort in patients with COVID-19 undergoing ECMO.

Completed1 enrollment criteria

Awake Prone Positioning for COVID-19 Acute Hypoxaemic Respiratory Failure

SurvivalProsthesis1 more

The objective of our study is to evaluate the effectiveness of prone position in preventing intubation or death in spontaneously ventilated patients with COVID-19 with acute respiratory failure.

Completed5 enrollment criteria

The Effect of Special Discharge Training in the COVID-19

COVID-19 Pneumonia

This study aimed to evaluate the impact of specialized discharge education on the daily life activities and quality of life of geriatric patients hospitalized in COVID-19 wards. The motivation behind this study stems from the vulnerability of elderly patients during the COVID-19 pandemic and the necessity of tailored education to support their daily life activities and enhance their quality of life after discharge. The primary objective of this article is to determine the specific type of specialized discharge education that geriatric patients in COVID-19 wards require to improve their ability to sustain daily life activities and enhance their quality of life. The central idea of this study is that providing specialized discharge education to geriatric patients in COVID-19 wards can result in improvements in their daily life activities and quality of life. The main findings of the study demonstrate a significant enhancement in daily life activities and quality of life among patients who received specialized discharge education. These individuals exhibited increased independence in mobility, improved performance in daily life activities, and reported an overall improvement in their quality of life. These findings underscore the significance of specialized discharge education for geriatric patients hospitalized in COVID-19 wards and highlight its positive impact on their health outcomes and quality of life.

Completed2 enrollment criteria

SARS-CoV-2 Nucleic Acid Detection Kit Clinical Performance Study

COVID-19Coronavirus Disease 20192 more

SARS-CoV-2 Nucleic Acid Detection Kit is an In Vitro Diagnostic (IVD) medical device intended for RNA detection of SARS-CoV-2 in human specimens using multiplex real-time polymerase chain reaction (RT-PCR) technology. The conserved regions of ORF1ab and N genes are used as target sites of the primers and probes according to the indications provided in the Instructions for Use (IFU).

Completed6 enrollment criteria

Study of the Use of the Ingaron in Volunteers for the Prevention of COVID-19

COVID-19 Respiratory Infection

The main purpose of this study is to evaluate the effectiveness of the prophylactic use of Ingaron (INN: recombinant interferon gamma human, lyophilisate for solution for intranasal administration 100,000 IU) in the regimen of 3 drops in each nasal passage intranasally every other day for 10 days with a break of 7 days (2 10-day cycles) in volunteers.

Completed12 enrollment criteria

Anxiety, Depression, and Quality of Life in Patients With Fibromyalgia During the Coronavirus Disease...

FibromyalgiaCoronavirus Disease 2019 Pandemic

Fibromyalgia patients and controls living in the same household will be evaluated for levels of resilience, covid-19 related anxiety, coronavirus disease 2019 related obsession, quality of life and pain and comparisons and correlation analyses will be carried out.

Completed7 enrollment criteria
1...552553554...721

Need Help? Contact our team!


We'll reach out to this number within 24 hrs